Company Filing History:
Years Active: 2001-2009
Title: The Innovations of Tamotsu Shigehisa
Introduction
Tamotsu Shigehisa is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals. With a total of 4 patents to his name, his work has the potential to revolutionize organ transplantation and medical treatments.
Latest Patents
One of Shigehisa's notable inventions is a transgenic mammal designed to carry a transgene comprising regulatory genes capable of functioning in hyperacute rejection-occurring local cells. This mammal also includes a gene encoding human N-acetylglucosaminyltransferase III (GnT-III). The innovation aims to effectively inhibit hyperacute rejection caused by discordant xenotransplantation, making it suitable for organ transplantation. Another significant patent involves transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55). This invention provides nonhuman transgenic mammals that can be utilized as laboratory animals in medical and pharmacological fields, as well as sources of organs and tissues for human medical treatment.
Career Highlights
Tamotsu Shigehisa is currently associated with Nippon Meat Packers, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential applications in improving organ transplantation outcomes and enhancing medical treatments.
Collaborations
Shigehisa has collaborated with notable colleagues, including Hiroshi Murakami and Koji Toyomura. Their combined expertise has contributed to the success of various projects and innovations in the field.
Conclusion
Tamotsu Shigehisa's contributions to biotechnology through his innovative patents highlight the importance of transgenic research in medicine. His work not only addresses critical challenges in organ transplantation but also paves the way for future advancements in medical treatments.